CINQAIR 100 MG in 10 ML Injection
- RxCUI
- 1746898
- RxNorm name
- CINQAIR 100 MG in 10 ML Injection
- Display name
- CINQAIR 100 MG in 10 ML Injection
- Full name
- CINQAIR 100 MG in 10 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:46
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761033 | Cinqair | reslizumab | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CINQAIR | RESLIZUMAB | Teva Respiratory, LLC | 053b9158-2a5b-48b9-bf47-5fa78a35ec33 | 2020-02-29 | Boxed warning, Warnings, Adverse reactions | 1746898 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 053b9158-2a5b-48b9-bf47-5fa78a35ec33 | CINQAIR 100 MG in 10 ML Injection [PSN] · 10 ML reslizumab 10 MG/ML Injection [Cinqair] [SBD] · 10 ML Cinqair 10 MG/ML Injection [SY] · Cinqair 100 MG per 10 ML Injection [SY] | 4 | 14 | These highlights do not include all the information needed to use CINQAIR safely and effectively. See full prescribing information for CINQAIR. CINQAIR ® (reslizumab) injection, for intravenous use Initial U.S. Approval: 2016 | 20200229 |